Randy Sallee

Randy Sallee currently serves as the Vice President of Scientific Affairs at Ironshore Pharmaceuticals & Development, Inc., focusing on pipeline development and lifecycle management since May 2017. Additionally, Randy Sallee holds the position of Chief Medical Officer at P2D Bioscience since July 2003 and has extensive experience in neuropharmacology and clinical pharmacology as a Research Scientist and Business Development professional at the University of Cincinnati from July 1998 to June 2015, where the title of Professor Emeritus was also held. Prior positions include Director of Clinical Pharmacology at Cincinnati Children’s Hospital Medical Center and Professor of Psychiatry and Pharmacology at the Medical University of South Carolina. Educational qualifications include a Ph.D. in Pharmacology from the University of Pittsburgh School of Medicine and an MD from Southern Illinois University School of Medicine.